CLINICAL STUDY OF NAFCILLIN FOR STAPHYLOCOCCAL SOFT TISSUE AND MUCOUS MEMBRANE INFECTIONS IN A GENERAL PRACTICE.
D000038:Abscess; D000818:Animals; D002270:Carbuncle; D002481:Cellulitis; D002648:Child; D002701:Chloramphenicol; D004351:Drug Resistance; D004352:Drug Resistance, Microbial; D004917:Erythromycin; D005667:Furunculosis; D058006:General Practice; D006801:Humans; D008417:Mastoiditis; D009092:Mucous Membrane; D009254:Nafcillin; D010019:Osteomyelitis; D010309:Parotitis; D010400:Penicillin G; D010406:Penicillins; D000039:Peritonsillar Abscess; D013203:Staphylococcal Infections; D013210:Staphylococcus; D014217:Troleandomycin; D014456:Ulcer
D010406:Penicillins; D009254:Nafcillin; D004917:Erythromycin; D002701:Chloramphenicol; D014217:Troleandomycin; D010400:Penicillin G
ABSCESS; ABSCESS, PERITONSILLAR; CARBUNCLE; CELLULITIS; CHILD; CHLORAMPHENICOL; DRUG RESISTANCE, MICROBIAL; ERYTHROMYCIN; FURUNCULOSIS; MASTOIDITIS; OSTEOMYELITIS; PAROTITIS; PENICILLIN; PENICILLIN G; STAPHYLOCOCCAL INFECTIONS; TRIACETYLOLEANDOMYCIN; ULCER